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Gut microbiota contributes to the biological activities of berry anthocyanins by transforming 
them into bioactive metabolites, and anthocyanins support the growth of specific bacteria, 
indicating a two-way relationship between anthocyanins and microbiota. In the present study, we 
tested the hypothesis that strawberry supplementation alters gut microbial ecology in diabetic 
db/db mice. Control (db/+) and diabetic (db/db) mice (7 weeks old) consumed standard diet or 
diet supplemented with 2.35% freeze-dried strawberry (db/db + SB) for 10 weeks. Colon 
contents were used to isolate bacterial DNA. V4 variable region of 16S rRNA gene was 
amplified. Data analyses were performed using standardized pipelines (QIIME 1.9 and R 
packages). Differences in predictive metagenomics function were identified by PICRUSt. 
Principal coordinate analyses confirmed that the microbial composition was significantly 
influenced by both host genotype and strawberry consumption. Further, α-diversity indices and 
β-diversity were different at the phylum and genus levels, and genus and operational taxonomical 
units levels, respectively (P<.05). At the phylum level, strawberry supplementation decreased the 
abundance of Verrucomicrobia in db/db + SB vs. db/db mice (P<.05). At the genus level, db/db 
mice exhibited a decrease in the abundance of Bifidobacterium, and strawberry supplementation 
increased Bifidobacterium in db/db + SB vs. db/db mice (P<.05). PICRUSt revealed significant 
differences in 45 predicted metabolic functions among the 3 groups. Our study provides evidence 
for marked changes in the composition and functional potential of the gut microbiome with 
strawberry supplementation in diabetic mice. Importantly, strawberry supplementation increased 
the abundance of beneficial bacteria Bifidobacterium which play a pivotal role in the metabolism 
of anthocyanins. 
 





Funding: This work was supported by the National Institute of Food and Agriculture (grant 
2018-67018-27510), University of Utah research start-up fund, University of Utah Seed 
Grant and College of Health Pilot Grant (to P.V.A.B.); the University of Utah Undergraduate 
Research Opportunities Program award (to K.W., J.E.M.); American Heart Association 
(AHA: 16GRNT31050004) and the National Institutes of Health (NIH: R03AGO52848) (to 




Anthocyanins are one of the major flavonoid compounds present in many fruits and vegetables 
including blueberries and strawberries [1]. Anthocyanins are glycosides comprised of an 
aglycone component (anthocyanidins such as cyanidin, delphinidin, malvidin, peonidin, 
pelargonidin and petunidin) and a sugar moiety (glucose, xylose, galactose and arabinose) [1]. 
Epidemiological and clinical studies support the beneficial health effects of berry anthocyanins 
such as reducing the risk of cardiovascular disease [2], [3], [4], [5]. The health benefits of berry 
anthocyanins are ascribed to their antihypertensive, antioxidant and antiatherosclerotic 
effects [3], [4]. Anthocyanins are extensively metabolized by digestive enzymes and intestinal 
microbiota in humans, suggesting that a significant portion of the biological activity of 
anthocyanins may be linked to their metabolites [6], [7]. Data from our laboratory and others 
suggest that the circulating metabolites mediate the beneficial vascular and endothelial effects of 
anthocyanins [8], [9], [10]. 
 
Strawberry is an excellent source of dietary anthocyanins, and the most commonly found 
anthocyanins in strawberries are the glycosidic derivatives of pelargonidin and cyanidin [5]. 
Epidemiological study demonstrated that habitual consumption of 2–3 servings (~160–240 g) of 
strawberries per week reduces the risk of myocardial infarction in humans [2]. Further, 
strawberry intake attenuated postprandial inflammation in overweight adults and reduced 
inflammatory molecules in humans with cardiovascular risk factors [11], [12], [13]. Recently, we 
showed that dietary supplementation of strawberry at a nutritional dosage (equivalent to two 
human servings) reduced vascular inflammation and ameliorated vascular dysfunction in diabetic 
mice [10]. Further, our study suggested that circulating metabolites mediate the vascular effects 
of strawberry anthocyanins [10]. Gut microbiota contributes significantly to the biological 
activities of berry anthocyanins by transforming them into more readily absorbable bioactive 
metabolites [6], [7]. Interestingly, anthocyanins promote intestinal colonization and support the 
growth of specific groups of bacteria, indicating a two-way relationship between anthocyanins 
and microbiota [7], [14]. Indeed, anthocyanins may act as prebiotics and play a role in reshaping 
the gut microbiome, which enhances the host microbial interaction to provide beneficial health 
effects in humans [7]. 
 
Healthy gut microbiota plays a major role in converting anthocyanins into bioactive metabolites. 
Therefore, it is one of the important factors required for the potential biological activities of 
anthocyanins. Anthocyanins in strawberry extracts were shown to enhance the beneficial effects 
of diets with fructooligosaccharides (a constituent of dietary fiber which has prebiotic properties) 
in the rat cecal environment [15]. However, to our knowledge, the effect of strawberry on gut 
microbiota in general and diabetes in particular is unknown. In the present study, we tested the 
hypothesis that dietary supplementation of strawberry induces changes in the composition and 
functional potential of the gut microbiome in diabetic db/db mice. 
 
2. Materials and methods 
 
2.1. Experimental animals 
 
db/db mice homozygous for the diabetes spontaneous mutation (Leprdb) with C57BL/6J 
background manifest morbid obesity, pancreatic cell atrophy and chronic hyperglycemia. These 
leptin-receptor-deficient db/db mice are a widely used type 2 diabetic animal model which 
exhibits dysbiosis of gut microbiota [16], [17], [18]. Six-week-old male diabetic db/db mice and 
control db/+ mice (stock no. 000642) were obtained from the Jackson Laboratories (Bar Harbor, 
ME, USA). The mice were held under humane conditions in the animal facility at the University 
of Utah and acclimated for a week before experiments were performed. Mice were housed 4 per 
cage and maintained under artificial light in a 12-h light/dark cycle, 23°C±1°C and 45%±5% 
humidity. The Institutional Animal Care and Use Committee at the University of Utah approved 
the animal experiment protocols which conformed to the Guide for the Care and Use of 
Laboratory Animals published by the US National Institute of Health. 
 
2.2. Experimental groups 
 
The freeze-dried strawberry powder was provided by FutureCeuticals (Momence, IL, USA). The 
customized pelleted diets (control diet and strawberry supplemented diet) were prepared as 
reported in our recent study and supplied by Dyets Inc. (Bethlehem, PA, USA) [10]. The 
strawberry-supplemented diet was adjusted to compensate for the fiber and additional sugars 
provided by the freeze-dried strawberry powder. The composition of the control diet and 
strawberry supplemented diet was reported in our recent study [10]. The amount of freeze-dried 
strawberry powder used in this study was calculated based on the Food and Drug Administration 
recommendation for the extrapolation of doses from humans to animals by normalization to body 
surface area [19]. The nutritional dose of freeze-dried strawberry powder was based on average 
human consumption. The dose used in these studies [2.35% freeze-dried strawberry powder in 
the diet pellets (w/w)] is equivalent to two human servings of fresh strawberries (~160 g 
strawberries) [10]. After 1 week of acclimation, diabetic mice (7 weeks old) were divided into 2 
groups and received control diet (n=8) or 2.35% freeze-dried strawberry-supplemented diet for 
10 weeks (n=8). db/+ mice fed control diet for 10 weeks served as controls (n=8). At the end of 
the 10-week treatment, mice were euthanized, and colon contents were collected, snap-frozen 
in liquid nitrogen and stored at −80°C. 
 
2.3. Microbial community profiling using 16S rRNA amplicon sequencing 
 
Genomic DNA was extracted from colon contents using the DNeasy PowerSoil Kit (Qiagen, 
MD, USA). Fifty nanograms of genomic DNA was utilized for amplification of the V4 variable 
region of the 16S rRNA gene using 515F/806R primers. Forward and reverse primers were dual-
indexed as described by Kozich et al. [20] to accommodate multiplexing of up to 384 samples 
per run. Paired-end sequencing (2× 250 bp) of pooled amplicons was carried out on an Illumina 
MiSeq [21] with ~30% PhiX DNA. 
 
2.4. Bioinformatics analysis 
 
Processing and quality filtering of reads were performed using scripts in QIIME (v1.9.1) [22] 
and other in-house scripts. Paired reads were stitched with PEAR, an overlapping paired-end 
reads merging algorithm which evaluates all possible paired-end read overlaps, minimizing false-
positive hits [23]. Reads were further filtered based on Phred quality scores and for chimeric 
reads using USEARCH61 [24]. Filtered reads were demultiplexed within QIIME, and samples 
with less than 5000 reads were excluded from further analysis. UCLUST was used to cluster 
sequences into operational taxonomical units (OTUs based on>97% identity) [24]. OTU picking 
was performed using open-reference method which encompasses clustering of reads against a 
reference sequence collection and also performs de novo OTU picking on the reads which fail to 
align to any known reference sequence in the database [25]. To eliminate erroneous mislabeling, 
the resulting OTU tables were checked for mislabeling sequences [26]. Representative sequences 
were further aligned using PyNAST with the Greengenes core-set alignment template [27]. 
Construction of the phylogenetic tree was performed using the default (FASTTREE) method in 
QIIME [28]. 
 
All samples were clustered based on their between-sample distances using UPGMA, and 
subsequent jack-knifing was performed by resampling methods. Comparisons of intergroup and 
intragroup diversity were performed using analysis of variance (ANOVA) including correction 
for multiple comparisons. OTU reads were summed at genus levels and then assessed for group 
differences with negative binomial regression using the DESeq2 package. PICRUSt was used to 
identify differences in predictive metagenome function [29]. OTUs were normalized by the 
predicted 16S copy number, and functions were predicted with the use of GreenGenes 13_5 
databases for KEGG Orthologs. 
 
2.5. Statistical analysis 
 
Microbiota OTU reads were imported into R version 3.2.1, and all statistical analyses were 
performed using the vegan and phyloseq packages unless specifically noted. OTU richness was 
measured by Chao1, and evenness was measured by several diversity indices (Shannon, 
Simpson, Inverse Simpson and Fisher). Group differences in α-diversity (richness and diversity) 
were assessed by ANOVA. Between-specimen diversity (β-diversity) was assessed by 
calculating a matrix of dissimilarities using the Bray–Curtis method and then visualized using 
nonmetric multidimensional scaling. Group differences in β-diversity were assessed using 
permutational multivariate analysis of variance with 500 permutations. Group differences among 
genus-level OTUs were assessed by pairwise comparisons on read counts using negative 
binomial Wald tests from the DESeq2 package. OTU relative abundance is given as median % 
relative abundance when described in text. All statistical tests used on 16S-rRNA gene 
sequencing data were considered significant at P≤.05. All tests were corrected for multiple 
comparisons using the false discovery rate correction by Benjamini and Hochberg. Associations 
among selected variables were assessed with Spearman's correlations. An in-house-developed R-
based shiny app (DAME) was developed to facilitate procedures and statistical analysis 
described above [30]. All statistical analyses were performed and figures were made using R. 
Correlations between bacterial abundance with predicted metagenomic function were performed 
using the corrplot package in R and utilized bacteria at family or genus levels as described in the 




3.1. α-Diversity and β-diversity 
 
In the present study, a total of 480,321 reads were assessed. A total of 320 of OTUs were 
assigned to taxonomic classifications of 6 phyla, 17 families and 30 genera. Principal coordinate 
analysis of unweighted UniFrac distances performed on the OTU abundance matrix showed that 
the β-diversity of gut microbial communities was significantly different between the groups and 
microbial composition was significantly influenced by both genotype (db/db) and strawberry 
consumption (Fig. 1A). 
 
 
Fig. 1. (A) Principal component analysis plot. Nonmetric multidimensional scaling analysis of 
the OTU abundance matrix of β-diversity of gut microbial communities at phylum (B), family 
(C), genus (D) and OTU (E) levels. Values are mean±S.E.M.; n=8. db/+, standard-diet-fed 
control mice; db/db, standard-diet-fed diabetic mice; db/db + SB, strawberry-fed diabetic mice. 
 
Measurements of α-diversity are indicative of phylogenetic species richness and evenness within 
a sample. Indices of α-diversity such as ACE, Chao1, Fisher, InvSimpson, Observed, Shannon 
and Simpson were measured. At the phylum level, α-diversity indices ACE, Chao1, Fisher and 
Observed were significantly different at phylum level among groups (Table 1). At the genus 
level, α-diversity indices such as Fisher and Observed were significantly different among groups 
(Table 2). β-Diversity represents compositional differences between samples (Fig. 1B–E). β-
Diversity, a measure of global microbial composition, was significantly different at the genus 
and OTU levels (Fig. 1D and E). β-Diversity was influenced by genotype and diet at OTU levels 
(Fig. 1E). 
 
Table 1. α-Diversity indices at phylum level 
Index db/+ db/db db/db + SB P value 
ACE 5.167±0.144 6.017±0.217 6.187±0.162 .006 
Chao1 5.125±0.125 5.75±0.164 5.875±0.125 .002 
Fisher 0.486±0.016 0.542±0.018 0.565±0.013 .006 
InvSimpson 2.129±0.103 2.364±0.187 2.025±0.041 .173 
Observed 5.125±0.125 5.75±0.164 5.875±0.125 .002 
Shannon 0.807±0.044 0.943±0.084 0.778±0.043 .142 
Simpson 0.524±0.019 0.558±0.036 0.505±0.01 .305 
Data are expressed as means±S.E. (n=8). db/+, standard-diet-fed control mice; db/db, standard-diet-fed diabetic 
mice; db/db + SB, strawberry-fed diabetic mice. 
 
Table 2. α-Diversity indices at genus level 
Index db/+ db/db db/db + SB P value 
ACE 23.63±0.501 22.069±0.858 25.4±3.57 .554 
Chao1 23.062±0.538 21.562±0.741 22.562±1.551 .590 
Fisher 2.539±0.069 2.244±0.062 2.247±0.066 .006 
InvSimpson 3.108±0.322 3.421±0.449 2.491±0.062 .139 
Observed 22.625±0.596 20.625±0.532 20.25±0.491 .012 
Shannon 1.463±0.071 1.48±0.109 1.257±0.025 .095 
Simpson 0.657±0.03 0.668±0.046 0.597±0.01 .266 
Data are expressed as means±S.E. (n=8). 
 
3.2. Relative abundance of microbiota at the phyla level 
 
The distribution of bacterial taxa and the relative abundance of bacteria at the phyla level are 
shown in Fig. 2A–G. Bacterial sequences were distributed among six bacterial phyla including 
Actinobacteria, Bacteroidetes, Firmicutes, Proteobacteria, Tenericutes and Verrucomicrobia. 
The taxonomic abundance indicated a significant (P<.05) decrease in Actinobacteria in db/db 
mice compared with db/+ mice (Fig. 2B). Strawberry supplementation did not increase the 
abundance of Actinobacteria in db/db + SB mice (Fig. 2B). The most abundant phyla were 
Bacteroidetes and Firmicutes (>90%). In the present study, the abundance of Bacteroidetes and 
Firmicutes was similar among three groups (Fig. 2C and D). The taxonomic abundance indicated 
a significant increase (P<.05) in Proteobacteria in db/db vs. db/+ mice, but strawberry 
supplementation did not alter the abundance of Proteobacteria in db/db + SB mice vs. db/+ mice 
(Fig. 2E). The abundance of Tenericutes was similar among the groups (Fig. 2F). There was a 
nonsignificant increase in Verrucomicrobia in db/db compared with db/+ mice, but this was 
significantly reduced (P<.05) in db/db + SB mice compared with db/db mice (Fig. 2G). 
 
 
Fig. 2. (A) The relative abundance of bacterial population at phylum level. The abundance 
of Actinobacteria (B), Bacteroidetes (C), Firmicutes (D), Proteobacteria (E), Tenericutes (F) 
and Verrucomicrobia (G) in db/+, db/db and db/db + SB mice treated for 10 weeks. *P<.05; 
values are mean±S.E.M.; n=8. NS, nonsignificant. 
 
3.3. Relative abundance of microbiota at the genus level 
 
The abundance of Bifidobacterium, which belong to the phylum Actinobacteria, is significantly 
decreased in db/db mice as compared to db/+ mice (P<.05) (Fig. 3A). However, strawberry 
supplementation significantly decreased the abundance of Bifidobacterium in db/db + SB mice 
(P<.05) (Fig. 3A). The abundance of Bacteroides was unchanged between db/+ and db/db mice 
(Fig. 3B). Strawberry supplementation significantly increased Bacteroides in db/db + SB mice 
(P<.05) (Fig. 3B). Dehalobacterium and Dorea, which belong to Firmicutes phyla, were 
significantly increased in db/db mice compared with db/+ mice (P<.05) (Fig. 3C and D). 
Lactobacillus, SMB53 and Turicibacter, which belong to the phylum Firmicutes, were 
significantly decreased in db/db mice compared with db/+ mice (P<.05) (Fig. 3E–G). Strawberry 
supplementation did not change the abundance of Dehalobacterium, Dorea, Lactobacillus, 
SMB53 and Turicibacter in db/db + SB mice compared with db/db mice. Akkermansia is 
significantly reduced in db/db + SB mice compared with db/db mice (P<.05) (Fig. 3H). In 
addition, the unassigned genera belong to the families Enterobacteriaceae and Ruminococcaceae 
were increased whereas Peptostreptococcaceae was decreased in db/db mice compared with 
db/+ mice (P<.05) (data not shown). Strawberry supplementation did not alter these genera 
in db/db + SB mice compared with db/db mice. 
 
 
Fig. 3. The abundance of Bifidobacterium (A), Bacteroides (B), Dehalobacterium (C), 
Dorea (D), Lactobacillus (E), SMB53 (F), Turicibacter (G) and Akkermansia (H) 
in db/+, db/db and db/db + SB mice treated for 10 weeks. *P<.05; values are mean±S.E.M.; n=8. 
 
3.4. Predicted metabolic pathways 
 
Predicted functional metagenomic profiles based on KEGG pathways were generated using 
PICRUSt. Comparison between groups revealed significant differences in 45 predicted metabolic 
functions (P<.05) (Fig. 4). Most of these features revealed similar abundances between control 
db/+ compared to db/db + SB. The correlations between bacterial abundance with predicted 
metagenomic function indicate that G-protein-coupled receptors, insulin signaling pathway, fatty 
acid elongation in mitochondria, glycerophospholipid metabolism, lipid biosynthesis protein, 
fatty acid biosynthesis and steroid hormone biosynthesis were significantly different among the 
three groups. Specifically, lipid biosynthesis proteins, insulin signaling pathway and the 




Fig. 4. Heat map for the effect of strawberry supplementation on functional potential of gut 
microbiome in diabetic mice. Metabolic pathways from KEGG module predictions using 16S 




The gut microbiome plays a pivotal role in the metabolism of anthocyanins and is one of the 
important mechanisms of the health-promoting properties of anthocyanins. We investigated the 
effect of dietary supplementation of strawberry on gut microbiota in diabetic mice. In our study, 
strawberry supplementation at a nutritional dosage induced marked changes in the composition 
and functional potential of the gut microbiome in diabetic db/db mice. 
 
Evidence from epidemiological and clinical studies indicates beneficial cardiovascular effects 
following the consumption of strawberries [2], [5], [12], [13]. Our group has also recently 
reported that dietary supplementation of strawberry attenuates vascular inflammation and 
improves vascular dysfunction in diabetic mice [10]. It has been speculated that such 
cardiovascular benefits may be mediated by circulating metabolites of the bioactive compounds 
of strawberries. These are produced by human digestive enzymes and intestinal microbiota, and 
highlight the potential importance of microbiota [31], [32], [33]. A human study indicated that 
21 polyphenolic metabolites appear in the plasma following the consumption of strawberries[31]. 
We recently assessed the role of circulating metabolites of strawberry in mediating the vascular 
effects of strawberry. We used serum that was obtained from strawberry-fed mice (serum 
containing circulating metabolites of strawberry) and control-diet-fed mice (control serum) for 
this study. In our study, serum from strawberry-fed mice reduced high-glucose- and palmitate-
induced endothelial inflammation in mouse aortic endothelial cells, indicating the possible role 
of circulating metabolites in mediating the vascular effects of strawberry [10]. 
 
Intestinal microbiotas play a major role in the conversion of anthocyanins to metabolites. 
Therefore, they modulate the biological activities of dietary anthocyanins. The commensal 
bacteria such as Bifidobacterium and Lactobacillus possess β-glucosidase activity and have the 
ability to metabolize anthocyanins into phenolic metabolites [34], [35]. Indeed, a recent 
randomized clinical study showed that high levels of Bifidobacterium are associated with 
increased urinary concentrations of anthocyanin metabolites [35]. On other hand, anthocyanins 
act as prebiotics and support the growth of Bifidobacterium and Lactobacillus, indicating a two-
way relationship between anthocyanins and gut microbiota [36]. Hence, a healthy microbiome is 
essential to benefit from the effects of anthocyanins as intestinal microbiota plays a key role in 
the conversion of parent anthocyanins into metabolites. 
 
In our study, db/db mice exhibited marked changes in the microbial abundance at phylum and 
genus levels. This is consistent with previous studies that showed the compositional changes in 
gut microbiota at phylum and genus levels in both type 1 and type 2 diabetes [37], [38], [39]. 
Actinobacteria, Proteobacteria and Verrucomicrobia were significantly altered among the three 
groups at the phylum level. There was a significant decrease in the abundance of Actinobacteria 
in db/db mice compared with db/+ mice. Actinobacteria represent only a small percentage but 
still are pivotal in the maintenance of gut homeostasis [40]. The classes of Actinobacteria, 
importantly Bifidobacterium, are widely used as probiotic, indicating their beneficial effects in 
many pathological conditions [40]. Actinobacteria were shown to decrease in type 1 diabetic 
children compared with healthy children [37]. Though strawberry supplementation increased the 
Actinobacteria in db/db + SB mice in our study, the difference did not reach significance. 
Consistent with a previous study, db/db mice exhibited a significant increase in Proteobacteria 
compared with control mice [38]. A bloom of Proteobacteria in the gut is an indication of an 
unstable gut microbial community and/or gut dysbiosis [41]. The levels of Proteobacteria were 
shown to increase in type 2 diabetic mice and diabetic patients [38], [39]. There was a 
nonsignificant increase in Verrucomicrobia in db/db compared with db/+ mice, but it was 
significantly reduced in db/db + SB mice compared with db/db mice. 
 
At the genus level, many of the bacterial genera were altered in db/db vs. db/+ and db/db vs. 
db/db + SB mice. The abundance of Bifidobacterium and Lactobacillus was significantly 
decreased in db/db mice compared to db/+ mice. Bifidobacterium and Lactobacillus are 
considered beneficial bacteria and are associated with positive effects for the host in the large 
intestine. Evidence shows that the etiology and development of type 2 diabetes are closely 
associated with changes in the gut microbiota including a decrease in the abundance of 
Bifidobacterium and Lactobacillus [42], [43]. These microbes modulate lipid and glucose 
metabolism, improve insulin resistance, reduce low-grade inflammation, improve the gut barrier 
function and stimulate the host immune system [7], [44], [45]. Indeed, the Bifidobacterium 
abundance was shown to be lower in overweight, obese or type 2 diabetic patients than in lean 
subjects [46], [47]. Further, a significant decrease in the number of Lactobacillus and 
Bifidobacterium was reported in children with diabetes [37]. In the present study, strawberry 
supplementation significantly increased the abundance of Bifidobacterium in db/db + SB mice 
compared to db/db mice but did not change the abundance of Lactobacillus. A recent study 
showed that incubating malvidin-3-glucoside, one of the major berry anthocyanins, with fecal 
slurry enhanced the growth of Bifidobacterium and Lactobacillus and exhibited a synergic effect 
to support the growth of beneficial bacteria when mixed with other anthocyanins [36]. Further, 
blueberry consumption for 6 weeks was shown to increase Bifidobacterium in human 
volunteers [48]. These studies indicate that the anthocyanins can act as a prebiotic to support the 
growth of beneficial gut bacteria such as Bifidobacterium. An increase in the Bifidobacterium 
can enhance the bioactivity of strawberry as it increases bioavailability of metabolites of 
anthocyanins [35]. 
 
Akkermansia was nonsignificantly increased in db/db mice compared to db/+ mice but was 
significantly reduced in db/db + SB mice compared with db/db mice. Studies suggest that 
Akkermansia muciniphila possesses anti-inflammatory properties, although the underlying 
mechanisms are unknown [49]. Akkermansia muciniphila was shown to protect against 
atherosclerosis and prevent the development of high-fat-diet-induced obesity by improving the 
gut barrier and metabolic inflammation in animal models [50]. Interestingly, in our study, 
strawberry supplementation reduced Akkermansia in db/db + SB mice. Given that we have 
previously shown that strawberries significantly improve vascular function and indices of 
vascular inflammation, the biological relevance of Akkermansia in the db/db model remains 
unclear. 
 
PICRUSt revealed significant differences in 45 predicted metabolic functions among the 3 
groups. Specifically, lipid biosynthesis proteins, the insulin signaling pathway and the 
phosphatidylinositol signaling pathway were modified in db/db + SB vs. db/db. Evidence 
suggests that oral supplementation of prebiotics (fermented oligosaccharides) and/or probiotics 
may improve metabolic disorders such as obesity and type 2 diabetes [51], [52]. A recent study 
showed that strawberry extracts modulate the effects of fructooligosaccharides on microbiota in 
the gastrointestinal tract [53]. To our knowledge, the present study is the first to show the 
complex interaction between strawberry and intestinal microbiota in diabetes. 
 
Our findings indicate that dietary supplementation of strawberry at a nutritional dosage induced 
marked changes in the composition and functional potential of gut microbiota in db/db mice. 
Importantly, strawberry supplementation increased the abundance of Bifidobacterium, which 
plays a pivotal role in the metabolism of anthocyanins and the formation of metabolites. Hence, 
the reported beneficial health effects of strawberry could be due to an increased abundance 
of Bifidobacterium, which may enhance the metabolism of strawberry and the bioactive 
metabolites formed by Bifidobacterium metabolism. However, mechanistic studies are still 
needed to provide evidence for the prebiotic effects of strawberry anthocyanins and to 
understand how this could modulate the biological activity of metabolites. Our results promote 
further exploration into the analysis of strawberry metabolites and correlating the functional 
aspects of strawberries with metabolites and microbiome. In conclusion, our study provides a 
strong proof of concept for further considering strawberry as an adjunct therapy to improve 
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